A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD-2282

NCT06858865 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolaemia

Interventions

DRUG: AD-228A
DRUG: AD-2281 and AD-2282

Sponsor

Addpharma Inc.